IL135499A0 - Bile acid salts of metals with physiogical action and use thereof in theraphy - Google Patents
Bile acid salts of metals with physiogical action and use thereof in theraphyInfo
- Publication number
- IL135499A0 IL135499A0 IL13549997A IL13549997A IL135499A0 IL 135499 A0 IL135499 A0 IL 135499A0 IL 13549997 A IL13549997 A IL 13549997A IL 13549997 A IL13549997 A IL 13549997A IL 135499 A0 IL135499 A0 IL 135499A0
- Authority
- IL
- Israel
- Prior art keywords
- bile acid
- physiogical
- theraphy
- metals
- action
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
- C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP1997/005555 WO1999019342A1 (en) | 1997-10-09 | 1997-10-09 | Bile acid salts of metals with physiological action and the use thereof in therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
IL135499A0 true IL135499A0 (en) | 2001-05-20 |
Family
ID=8166756
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13549997A IL135499A0 (en) | 1997-10-09 | 1997-10-09 | Bile acid salts of metals with physiogical action and use thereof in theraphy |
IL135499A IL135499A (en) | 1997-10-09 | 2000-04-06 | Bile acid salts of metals with physiological action and the use thereof in therapy |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL135499A IL135499A (en) | 1997-10-09 | 2000-04-06 | Bile acid salts of metals with physiological action and the use thereof in therapy |
Country Status (14)
Country | Link |
---|---|
US (1) | US6342489B1 (xx) |
EP (1) | EP1023314B1 (xx) |
JP (1) | JP2001519438A (xx) |
AT (1) | ATE232541T1 (xx) |
AU (1) | AU747019B2 (xx) |
CA (1) | CA2305764C (xx) |
DE (1) | DE69719095T2 (xx) |
DK (1) | DK1023314T3 (xx) |
ES (1) | ES2191825T3 (xx) |
HK (1) | HK1032064A1 (xx) |
IL (2) | IL135499A0 (xx) |
NO (1) | NO314761B1 (xx) |
NZ (1) | NZ503800A (xx) |
WO (1) | WO1999019342A1 (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
WO2012097155A1 (en) * | 2011-01-14 | 2012-07-19 | Chiasma Inc. | Improved pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof |
US20120237492A1 (en) | 2011-02-18 | 2012-09-20 | Kythera Biopharmaceuticals, Inc. | Treatment of submental fat |
US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1468922A1 (de) * | 1965-06-30 | 1969-06-19 | Riedel De Haen Ag | Verfahren zur Herstellung choleretisch wirksamer Derivate der 3-alpha-Hydroxy-7,12-diketocholansaeure |
US3620831A (en) * | 1968-12-30 | 1971-11-16 | Honeywell Inc | Electrographic recording medium |
GB1592791A (en) * | 1977-01-07 | 1981-07-08 | Radiochemical Centre Ltd | Selenium- or tellurium-containing bile acids and derivatives thereof |
US5079240A (en) * | 1990-03-15 | 1992-01-07 | The Regents Of The University Of California | Synthetic conjugated bile acid and method of use thereof |
US5174897A (en) * | 1991-09-24 | 1992-12-29 | The United States Of America As Represented By The Secretary Of Agriculture | Constructed wetlands to control nonpoint source pollution |
US5460812A (en) | 1992-06-22 | 1995-10-24 | Digestive Care Inc. | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
US5415872A (en) | 1992-06-22 | 1995-05-16 | Digestive Care Inc. | Compositions of gastric acid-resistant microspheres containing salts of bile acids |
US5578304A (en) * | 1992-06-22 | 1996-11-26 | Digestive Care Inc. | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
-
1997
- 1997-10-09 EP EP97909372A patent/EP1023314B1/en not_active Expired - Lifetime
- 1997-10-09 JP JP2000515913A patent/JP2001519438A/ja active Pending
- 1997-10-09 AU AU47081/97A patent/AU747019B2/en not_active Ceased
- 1997-10-09 NZ NZ503800A patent/NZ503800A/xx unknown
- 1997-10-09 DE DE69719095T patent/DE69719095T2/de not_active Expired - Fee Related
- 1997-10-09 IL IL13549997A patent/IL135499A0/xx active IP Right Grant
- 1997-10-09 US US09/509,891 patent/US6342489B1/en not_active Expired - Fee Related
- 1997-10-09 WO PCT/EP1997/005555 patent/WO1999019342A1/en active IP Right Grant
- 1997-10-09 DK DK97909372T patent/DK1023314T3/da active
- 1997-10-09 AT AT97909372T patent/ATE232541T1/de not_active IP Right Cessation
- 1997-10-09 CA CA002305764A patent/CA2305764C/en not_active Expired - Fee Related
- 1997-10-09 ES ES97909372T patent/ES2191825T3/es not_active Expired - Lifetime
-
2000
- 2000-04-06 IL IL135499A patent/IL135499A/en not_active IP Right Cessation
- 2000-04-07 NO NO20001812A patent/NO314761B1/no not_active IP Right Cessation
-
2001
- 2001-04-12 HK HK01102634A patent/HK1032064A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2191825T3 (es) | 2003-09-16 |
HK1032064A1 (en) | 2001-07-06 |
NO314761B1 (no) | 2003-05-19 |
IL135499A (en) | 2006-10-31 |
DK1023314T3 (da) | 2003-05-12 |
EP1023314B1 (en) | 2003-02-12 |
AU4708197A (en) | 1999-05-03 |
NO20001812L (no) | 2000-04-07 |
ATE232541T1 (de) | 2003-02-15 |
NZ503800A (en) | 2001-03-30 |
NO20001812D0 (no) | 2000-04-07 |
DE69719095T2 (de) | 2003-07-24 |
WO1999019342A1 (en) | 1999-04-22 |
EP1023314A1 (en) | 2000-08-02 |
JP2001519438A (ja) | 2001-10-23 |
AU747019B2 (en) | 2002-05-09 |
US6342489B1 (en) | 2002-01-29 |
CA2305764A1 (en) | 1999-04-22 |
CA2305764C (en) | 2008-04-08 |
DE69719095D1 (de) | 2003-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4299496A (en) | Novel multiple-substituent dtpa derivatives and metal complexes thereof, pharmaceutical compositions containing such complexes, their use in diagnosis and therapy, methods ofpreparing the complexing agents and complexes and methods of preparing the pharmaceutical compositions | |
GR3035831T3 (en) | Veterinary composition containing a proton pump inhibitor | |
ZA975866B (en) | Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases. | |
HUP0104867A3 (en) | Heterocyclic compounds useful in the treatment of inflammatory diseases, process for their preparation, pharmaceutical compositions comprising thereof and their use | |
HUP0301101A3 (en) | Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases | |
WO2002085299A3 (en) | Therapeutic treatments using the direct application of antimicrobial metal compositions | |
IS4083A (is) | Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja | |
EP0690722A4 (en) | COMPOSITION AND METHOD FOR REDUCING THE TOXICITY OF BIOLOGICALLY ACTIVE FACTORS | |
HK1050860A1 (en) | Nordihydroguaiaretic derivatives for use in treatment of tumors | |
HUP0105313A3 (en) | Potassium salt of (s)-omeprazole, process for its preparation and pharmaceutical composition containing the same and its use | |
HK1030144A1 (en) | Method for treatment of liver tumours and pharmaceutical compositions for use therein. | |
HK1045986A1 (en) | Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders. | |
EP0793660A4 (en) | 2-SUBSTITUTED 1,2,5-THIADIAZOLIDIN-3-ON-1,1-DIOXIDES, COMPOSITION AND THEIR USE | |
NZ513650A (en) | Pharmaceutical composition for the treatment of urinary incontinence, motion sickness and vertigo | |
IL143594A0 (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases | |
IL126235A (en) | Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use | |
IL135499A0 (en) | Bile acid salts of metals with physiogical action and use thereof in theraphy | |
PL318130A1 (en) | Terpenod derivatives (of sarcodictyine)as antineoplastic agents | |
AU8851298A (en) | L-threonate ferrous, as well as pharmaceutical composition and use for improvingand treating human anemia thereof | |
HUP0103570A3 (en) | Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism and pharmaceutical compositions containing them | |
KR100488038B1 (ko) | 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도 | |
HUP0300313A3 (en) | Compound, pharmaceutical composition containing it and its use for the treatment of pain | |
MY103584A (en) | 8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
HU9802142D0 (en) | Use of na+/h+ -ion-exchange inhibitors for producing pharmaceutical compositions for treating and profilacting diseases of the central nerve system | |
TW336220B (en) | L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed |